DM - Small molecule digital twin platform
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The FDA is forecasting a contract to complete the installation and integration of Siemens hardware and software systems to support small molecule digital twin projects, specifically focusing on a domestic manufacturing equipment setup. This effort centers on implementing a mixer from Glatt that enables signal exchange with third-party equipment, ensuring seamless communication and data flow within the digital twin ecosystem. The scope requires full technical integration of the Siemens platform to enable real-time monitoring, control, and optimization of manufacturing processes for small molecule pharmaceuticals, aligning with modern digital manufacturing standards. The contract is categorized under NAICS code 334516, indicating it pertains to the manufacturing of industrial process control equipment. The place of performance and specific agency office details are not yet defined, and the contracting officer designation is pending. All inquiries should be directed to the Cder Acquisition Liaison at cderacquisitions@fda.hhs.gov. This forecast signals the FDA’s intent to advance its digital manufacturing capabilities through advanced automation and data-driven production technologies, with a clear focus on domestic sourcing and system interoperability.
General Info
Agency
NAICS
Place of Performance
USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
